http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1919916_PMID

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656261_AID1919916_PMID_VALUE14
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476028384_AID1919916_PMID_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656273_AID1919916_PMID_VALUE18
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476028386_AID1919916_PMID_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656273_AID1919916_PMID_VALUE19
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656270_AID1919916_PMID_VALUE16
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656274_AID1919916_PMID_VALUE20
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656271_AID1919916_PMID_VALUE17
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID321902164_AID1919916_PMID_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID46518432_AID1919916_PMID_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476028386_AID1919916_PMID_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476028388_AID1919916_PMID_VALUE9
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656261_AID1919916_PMID_VALUE13
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656262_AID1919916_PMID_VALUE15
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476028383_AID1919916_PMID_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476028384_AID1919916_PMID_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656260_AID1919916_PMID_VALUE11
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID46518429_AID1919916_PMID_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656274_AID1919916_PMID_VALUE21
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID485656260_AID1919916_PMID_VALUE12
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476028388_AID1919916_PMID_VALUE10
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10253
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title Inhibition of rhGAA Determined by Fluopol-ABPP from US Patent US20230339856: \"NOVEL PHARMACOLOGICAL CHAPERONE COMPOUNDS OF HUMAN ACID ALPHA-GLUCOSIDASE AND THE THERAPEUTIC USE THEREOF\"
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485656261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485656273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID476028386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID476028388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485656262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID476028383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485656274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID46518432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485656271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID476028384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485656270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID46518429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485656260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID321902164
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1919916

Total number of triples: 40.